Summary
Translational Drug Development (TD2) is a drug development organization that specializes in providing oncology treatments to cancer patients. The organization provides services such as regulatory affairs services, preclinical services, clinical services, and others. It also offers in vivo services, isogenic cell lines, investigational new drug application services, toxicology support services, medical writing, program analysis, clinical trial management and pancreatic cancer research. The organization is an AAALAC-accredited facility and concentrates on non-GLP safety/tolerability, in vitro assays, DMPK services, syngeneic tumor models, orthotopic tumor models, tumor xenograft models, patient-derived tumor xenograft models, and others. TD2 is headquartered in Scottsdale, Arizona, the US.
Translational Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Translational Drug Development, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Translational Drug Development, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Translational Drug Development, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
PharmaCyte Biotech Partners with Translational Drug Development and Clinical Network Services 10
TD2 Enters into Agreement with Navigating Cancer 11
Forma Therapeutics Enters Into Co-Development Agreement With TGen Drug Development 12
TGen Drug Development Enters Into Co-Development Agreement With Flagship Biosciences 13
TGen Drug Enters Into Co-Development Agreement With Oncoholdings 14
TGen Drug Development Services Forms Joint Venture With Horizon Discovery 15
Translational Drug Development - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Translational Drug Development, Pharmaceuticals & Healthcare, Key Facts 1
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Translational Drug Development, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Translational Drug Development, Deals By Therapy Area, 2010 to YTD 2016 8
Translational Drug Development, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
PharmaCyte Biotech Partners with Translational Drug Development and Clinical Network Services 10
TD2 Enters into Agreement with Navigating Cancer 11
Forma Therapeutics Enters Into Co-Development Agreement With TGen Drug Development 12
TGen Drug Development Enters Into Co-Development Agreement With Flagship Biosciences 13
TGen Drug Enters Into Co-Development Agreement With Oncoholdings 14
TGen Drug Development Services Forms Joint Venture With Horizon Discovery 15
Translational Drug Development, Key Competitors 16
Translational Drug Development, Key Employees 17
List of Figures
Translational Drug Development, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Translational Drug Development, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Translational Drug Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8